Pharmaceutical Distribution DX Startup 9lione Raises Over ¥20 Million to Tackle Medical Surplus Waste

Funding Overview

9lione Inc., headquartered in Nerima Ward, Tokyo and led by Representative Director Yusuke Hirota, has announced that it has surpassed ¥20 million in funding during its ongoing Series A extension round conducted via the equity-based crowdfunding service "FUNDINNO." This achievement represents a funding rate exceeding 400% of its initial target.

About 9lione Inc.

9lione operates a digital transformation (DX) platform designed to solve the structural issue of "uneven distribution" within pharmaceutical supply chains. The company provides a system that connects medical institutions, allowing unused pharmaceuticals to be redistributed to facilities facing shortages. Currently, the number of registered medical facilities exceeds 1,200, and the annual gross merchandise value (GMV) has grown to over ¥2 billion.

Purpose of Funding and Future Outlook

With this capital injection, 9lione will accelerate the expansion of its healthcare network and strengthen its pharmaceutical distribution infrastructure. The primary uses of the funds are as follows:

• Expanding the medical institution network and acquiring facilities with surplus in-house medications
• Expanding sales bases nationwide
• Strengthening pharmaceutical logistics and quality control systems
• Developing systems for medical institutions and hiring sales representatives, engineers, and other personnel

The company aims to scale its current network—which is primarily focused on the Tokyo metropolitan area—to a nationwide level, thereby promoting stable pharmaceutical supplies.

About the Investors

This funding was raised through equity-based crowdfunding (FUNDINNO), gathering capital from a large number of individual retail investors rather than being underwritten by specific institutional investors.